Tilray Inc (NASDAQ:TLRY - Get Free Report)'s share price fell 0.9% during mid-day trading on Monday . The company traded as low as $1.67 and last traded at $1.68. 5,473,990 shares changed hands during trading, a decline of 78% from the average session volume of 25,135,387 shares. The stock had previously closed at $1.69.
Tilray Trading Down 2.4 %
The company has a debt-to-equity ratio of 0.10, a current ratio of 2.27 and a quick ratio of 1.42. The company has a 50-day moving average of $1.78 and a 200 day moving average of $1.87. The company has a market cap of $1.28 billion, a PE ratio of -3.75 and a beta of 2.13.
Tilray (NASDAQ:TLRY - Get Free Report) last released its quarterly earnings results on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The company had revenue of $229.90 million for the quarter, compared to analysts' expectations of $226.20 million. Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The business's quarterly revenue was up 24.8% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.15) EPS. Analysts predict that Tilray Inc will post -0.16 earnings per share for the current year.
Institutional Trading of Tilray
Institutional investors have recently added to or reduced their stakes in the company. Bank of Montreal Can increased its stake in Tilray by 19.6% in the second quarter. Bank of Montreal Can now owns 2,169,100 shares of the company's stock worth $3,622,000 after purchasing an additional 355,778 shares during the period. Lazard Asset Management LLC bought a new stake in Tilray during the 1st quarter valued at about $118,000. Avantax Advisory Services Inc. boosted its position in Tilray by 46.2% in the 1st quarter. Avantax Advisory Services Inc. now owns 53,110 shares of the company's stock valued at $131,000 after buying an additional 16,792 shares during the period. Concurrent Investment Advisors LLC purchased a new stake in Tilray in the 1st quarter valued at about $75,000. Finally, CIBC Asset Management Inc grew its stake in Tilray by 13.3% in the 2nd quarter. CIBC Asset Management Inc now owns 871,299 shares of the company's stock worth $1,445,000 after acquiring an additional 102,316 shares in the last quarter. Institutional investors own 9.35% of the company's stock.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Further Reading
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
